Clinical utility and characteristics of nine anti-HCV antibody screening reagents used in Japan

Clinical Laboratory

Volumn 55, Issue 1-2, 2009, Pages 9-22

  Kita, Mifumi ^a,b   Deguchi, Matsuo ^c   Kagita, Masanori ^c   Yoshioka, Nori ^c   Kobayashi, Eiji ^b   Watanabe, Mikio ^b   Asari, Seishi ^c   Yamanaka, Kiyoharu ^a   Iwatani, Yoshinori ^b  

^a OTEMAE HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti HCV antibody; RIBA III; Screening test

Indexed keywords

HEPATITIS C ANTIBODY; RECOMBINANT ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HEPATITIS C; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; JAPAN; MAJOR CLINICAL STUDY; SCREENING TEST; SENSITIVITY ANALYSIS; SEROCONVERSION; SOLID;

CHEMILUMINESCENT MEASUREMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOASSAY; JAPAN; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 63049138955     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lemon SM, et al. Hepatitis C Virus. In: Knipe DM, Howley PM eds. Fields Virology, 5th ed. Philadelphia, Lippincott Williams & Wilkins, 2007: 1253-1304.
2. Lemon SM, Brown EA. Hepatitis C virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principle and Practice of Infectious Disease, Fourth. New York, Churchill Livingstone, 1995: 1474-1486.
3. Purcell RH. Hepatitis C virus. In: Webster RG, Granoff A, eds. Encyclopedia of Virology. London, Academic Press Ltd, 1994: 569-574.
4. Walker CM. Hepatitis C virus. In: Ahmed R, Chen I, eds. Persistent Viral Infections. Chichester, Wiley, 1999: 93-115.
5. EASL International Consensus Conference on Hepatitis C. Consensus Statement. Journal of Hepatology, 1999, 31: 3-8.
6. The Hepatitis C Trust. World Hepatitis Day 2008 News from Around the World. World Health Hepatitis Day News, Up-date 23 May 2008. http://www.hepctrust.org.uk/news/2008/World+Hepatitis+Day+News/
7. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B hepatitis genome. Science 1989; 244: 359-62.
8. Kuo G, Choo Q-L, Alter H J, et al. An assay for circulating antibodies to major etiologic virus of human non-A, non-B hepatitis. Science 1989; 224: 362-4.
9. Courouce AM, Marrec NL, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 1994; 34: 790-5.
10. Barrera JM, Francis B, Ercilla G, et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995; 68: 15-18.
11. Kodama T, Ichiyama S, Sato K, Nada T, Nakashima N. Evaluation of membrane filter assay system, Ortho HCV Ab Quick Pack, for detection of anti-hepatitis C virus antibody. J Clin Microbiol 1998; 36: 1439-40.
12. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122-9.
13. Watterson JM, Stallcup P, Escamilla D, Chernay P, Reyes A, Trevino screening. Evaluation of the Ortho-Clinical Diagnostics Vitros ECi Anti-HCV test: comparison with three other methods. J Clin Lab Anal. 2007; 21: 162-6.
14. Suzuki N, Ito N, Atobe R, Ishikawa K. Antibody response to recombinant HCV antigens and detection of HCV RNA in serum samples of blood donors positive for anti-HCV by 2nd generation HCV antibody screening test, A comparison of reaction between PHA & PA II. Japanese Journal of Transfusion Medicine 1993; 39: 753-9. (in Japanese)
15. Polywka S, Schroter M, Feucht HH, Zoliner B, Laufs R. Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol 2001; 39: 1665-8.
16. Petitjean Lecherbonnier J, Gouarin S, Dina J, Vabret A, Freymuth F. Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV). Pathol Biol. 2007 Dec; 55: 512-20.
17. Oohira H, Kagita M, Deguchi M, et al. Determination of HCV Antibody using the Fully Automated Chemiluminescent Enzyme Immunoassay Analyzer LUMIPULSE f. Japanese Journal of Clinical Laboratory Automation 1999; 24: 159-62. (in Japanese)
18. Denoyel G, van Helden J, Bauer R, Preisel-Simmons B. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System. Clin Lab. 2004; 50: 75-82.
19. Poel CL, Cuypers HTM, Reesink HW. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317-19.
20. Hsieh MY, Lee LP, Hou NJ, et al. Qualitative application of COBAS AMPLICOR HCV test version 2.0 assays in patients with chronic hepatitis C virus infection and comparison of clinical performance with version 1.0. Kaohsiung J Med Sci. 2007 Jul; 23(7): 332-8.